会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 3. 发明授权
    • Piperazine compounds as inhibitors of MMP or TNF
    • 哌嗪化合物作为MMP或TNF的抑制剂
    • US06333324B1
    • 2001-12-25
    • US09319928
    • 1999-07-26
    • Masahiro NeyaHitoshi YamazakiNatsuko KayakiriKentaro SatoTeruo Oku
    • Masahiro NeyaHitoshi YamazakiNatsuko KayakiriKentaro SatoTeruo Oku
    • C07D24104
    • C07D405/12C07D241/04C07D405/14C07D409/12C07D409/14C07D413/14C07D417/12C07D417/14
    • A compound of formula (I) wherein A is a sulfonyl or a carbonyl; R1 is an optionally substituted aryl, an optionally substituted heterocyclic group, an optionally substituted lower alkyl or an optionally substituted lower alkenyl; R2 is a hydrogen, an optionally substituted lower alkyl, an optionally substituted aryl or an optionally substituted heterocyclic group; R3 is an optionally substituted lower alkyl, an optionally substituted lower alkoxy, an optionally substituted aryloxy, an optionally substitued lower alkenyl, an optionally substituted aryl, an optionally substituted heterocyclic group or an optionally substitued amino; R4 is a hydrogen, an optionally substituted lower alkyl, an optionally substituted aryl or an optionally substituted heterocyclic group; R5 is a hydrogen, an optionally substituted lower alkyl, an optionally substituted aryl or an optionally substituted heterocyclic group; and R10 is a hydroxy or a protected hydroxy, and a pharmaceutically acceptable salt thereof. The compound of the present invention is useful as a medicament for prophylactic and therapeutic treatment of MMP- or TNF&agr;-mediated diseases.
    • 式(I)的化合物,其中A是磺酰基或羰基; R1是任选取代的芳基,任选取代的杂环基,任选取代的低级烷基或任选取代的低级烯基; R2是氢,任选取代的低级烷基,任选取代的芳基或任选取代的杂环基; R 3是任选取代的低级烷基,任选取代的低级烷氧基,任选取代的芳氧基,任选取代的低级烯基,任选取代的芳基,任选取代的杂环基或任选取代的氨基; R4是氢,任选取代的低级烷基,任选取代的芳基或任选取代的杂环基; R5是氢,任选取代的低级烷基,任选取代的芳基或任选取代的杂环基; R 10为羟基或被保护的羟基及其药学上可接受的盐。 本发明的化合物可用作用于预防和治疗MMP或TNFα介导的疾病的药物。
    • 4. 发明授权
    • Piperazine compounds as inhibitors of MMP or TNF
    • 哌嗪化合物作为MMP或TNF的抑制剂
    • US06489324B2
    • 2002-12-03
    • US09982869
    • 2001-10-22
    • Masahiro NeyaHitoshi YamazakiNatsuko KayakiriKentaro SatoTeruo Oku
    • Masahiro NeyaHitoshi YamazakiNatsuko KayakiriKentaro SatoTeruo Oku
    • C07D24104
    • C07D405/12C07D241/04C07D405/14C07D409/12C07D409/14C07D413/14C07D417/12C07D417/14
    • A compound of formula (I) wherein A is a sulfonyl or a carbonyl; R1 is an optionally substituted aryl, an optionally substituted heterocyclic group, an optionally substituted lower alkyl or an optionally substituted lower alkenyl; R2 is a hydrogen, an optionally substituted lower alkyl, an optionally substituted aryl or an optionally substituted heterocyclic group; R3 is an optionally substituted lower alkyl, an optionally substituted lower alkoxy, an optionally substituted aryloxy, an optionally substituted lower alkenyl, an optionally substituted aryl, an optionally substituted heterocyclic group or an optionally substituted amino; R4 is a hydrogen, an optionally substituted lower alkyl, an optionally substituted aryl or an optionally substituted heterocyclic group; R5 is a hydrogen, an optionally substituted lower alkyl, an optionally substituted aryl or an optionally substituted heterocyclic group; and R10 is a hydroxy or a protected hydroxy, and a pharmaceutically acceptable salt thereof. The compound of the present invention is useful as a medicament for prophylactic and therapeutic treatment of MMP-or TNF&agr;-medicated diseases.
    • 式(I)的化合物,其中A是磺酰基或羰基; R1是任选取代的芳基,任选取代的杂环基,任选取代的低级烷基或任选取代的低级烯基; R2是氢,任选取代的低级烷基,任选取代的芳基或任选取代的杂环基; R3是任选取代的低级烷基,任选取代的低级烷氧基,任选取代的芳氧基,任选取代的低级烯基,任选取代的芳基,任选取代的杂环基或任选取代的氨基; R4是氢,任选取代的低级烷基,任选取代的芳基或任选取代的杂环基; R5是氢,任选取代的低级烷基,任选取代的芳基或任选取代的杂环基; R 10为羟基或被保护的羟基及其药学上可接受的盐。 本发明的化合物可用作用于预防和治疗MMP或TNFα药物疾病的药物。
    • 8. 发明授权
    • Peptide compounds, their preparation and uses
    • 肽化合物,其制备和用途
    • US5888972A
    • 1999-03-30
    • US564271
    • 1997-06-24
    • Keiji Hemmi, deceasedMasahiro NeyaNaoki FukamiNatsuko KayakiriHirokazu Tanaka
    • Keiji Hemmi, deceasedMasahiro NeyaNaoki FukamiNatsuko KayakiriHirokazu Tanaka
    • A61K38/00A61P9/12C07K5/02C07K5/03C07K5/062C07K5/08C07K5/083A61K38/06A61K38/07
    • C07K5/0808C07K5/0207C07K5/0827A61K38/00Y02P20/55
    • A compound of the formula: ##STR1## in which R.sup.4 is acyl,R.sup.5 is lower alkyl,R.sup.6 is optionally substituted ar(lower)alkyl or optionally substituted heterocyclic-(lower)alkyl,R.sup.7 is lower alkyl or lower alkylthio(lower)alkyl,R.sup.8 is carboxy or protected carboxy,A is lower alkylene,Z is a group of the formula: ##STR2## wherein R.sup.1 is hydrogen, lower alkyl, common amino-protective group or optionally substituted ar(lower)alkyl,R.sup.2 is hydrogen, lower alkyl, optionally substituted ar(lower)alkyl, optionally substituted heterocyclic-(lower)alkyl, optionally substituted cyclo(lower)alkyl(lower)alkyl, common amino-protective group, amino(or protected amino)(lower)alkyl, optionally substituted heterocyclic-carbonyl or cyclo(lower)alkyl, andR.sup.3 is optionally substituted heterocyclic(lower)alkyl, andm is an integer of 0 to 2,or pharmaceutically acceptable salts thereof, useful as endothelin antagonist.
    • PCT No.PCT / JP94 / 01042 Sec。 371日期1996年6月24日 102(e)1996年6月24日PCT 1994年6月28日PCT公布。 公开号WO95 / 00537 日期1995年1月5日具有下式的化合物:其中R 4为酰基,R 5为低级烷基,R 6为任选取代的芳(低级)烷基或任选取代的杂环 - (低级)烷基,R 7为低级烷基或低级 烷硫基(低级)烷基,R 8为羧基或被保护的羧基,A为低级亚烷基,Z为下式基团:其中R 1为氢,低级烷基,普通氨基保护基或任选取代的芳(低级)烷基 (低级)烷基,任选取代的杂环 - (低级)烷基,任选取代的环(低级)烷基(低级)烷基,常用氨基保护基,氨基(或被保护的氨基)( 低级烷基,任选取代的杂环羰基或环(低级)烷基,R 3为任选取代的杂环(低级)烷基,m为0-2的整数,或其药学上可接受的盐,可用作内皮素拮抗剂。